Forbes
From Sugar To Psychedelics: The European Companies Testing Biosynthetic Psilocybin In Humans (September, 2021)
One European psychedelics company is on its way to testing out another, more unusual method of production, one that effectively turns sugar into psilocybin. Octarine Bio, a synthetic biology company based in Copenhagen, will soon bring its biosynthetic psilocybin into human clinical trials through a new partnership with Clerkenwell Health, a London-based contract research organization that specializes in psychedelic medicines.